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Abstract
There is growing evidence that mitochondrial dysfunction, and more specifically fatty acid b-oxidation impairment, is
involved in the pathophysiology of non-alcoholic steatohepatitis (NASH). The goal of the present study was to achieve more
understanding on the modification/s of carnitinepalmitoyltransferase-I (CPT-I), the rate-limiting enzyme of the
mitochondrial fatty acid b-oxidation, during steatohepatitis. A high fat/methionine-choline deficient (MCD) diet,
administered for 4 weeks, was used to induce NASH in rats. We demonstrated that CPT-I activity decreased, to the same
extent, both in isolated liver mitochondria and in digitonin-permeabilized hepatocytes from MCD-diet fed rats. At the same
time, the rate of total fatty acid oxidation to CO2 and ketone bodies, measured in isolated hepatocytes, was significantly
lowered in treated animals when compared to controls. Finally, an increase in CPT-I mRNA abundance and protein content,
together with a high level of CPT-I protein oxidation was observed in treated rats. A posttranslational modification of rat
CPT-I during steatohepatitis has been here discussed.
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Introduction
The term non-alcoholic steatohepatitis (NASH) describes
histopathological findings typical of alcoholic liver disease in a
group of patients without significant alcohol consumption [1].
NASH is observed in a subset of patients with non-alcoholic fatty
liver disease (NAFLD), a pathology comprising a wide spectrum of
liver damage, ranging from simple macrovescicular steatosis to
steatohepatitis, advanced fibrosis, and cirrhosis [1]. The clinical
relevance of these conditions is related to the high prevalence of
NAFLD in the population and to the possible evolution of NASH
towards end-stage liver disease, including hepatocellular carcino-
ma, as well as the need for liver transplantation [2]. Even though
the mechanisms of the progression from simple steatosis to NASH
are not completely understood, mitochondrial dysfunction has
been proposed as a key factor. Indeed, ultrastructural alterations,
impairment of ATP synthesis and increased production of reactive
oxygen species (ROS) have been reported in liver mitochondria
from NASH human patients and from rodent model for this
pathology [3–8].
Some of us have recently described an altered hepatic
mitochondrial function in rats affected by NASH induced by a
methionine-choline deficient (MCD) diet [4]. Rodents fed a MCD
diet develop a steatohepatitis producing hepatic lesions and
changes in liver redox balance, mimicking the impairment
observed in patients with NASH [9,10]. Fat accumulation
enhances mitochondrial ROS production [11] which, in turn,
may cause oxidative stress. The most important cellular damage
caused by ROS is peroxidation of membrane lipids resulting in
generalized alteration of the membrane function [12]. Lipid
peroxidation products can react with functional groups of amino
acids in proteins and enzymes to form adducts that may alter
protein function [13]. This has been well demonstrated for the
uncoupling protein 2 (UCP-2) in the same experimental model
used in this study [7].
During steatosis, hepatocytes are overloaded with free fatty
acids (FFA), but the liver does not enlarge indefinitely; the
hepatocytes reach a new energetic steady state, whereby the
increased hepatic FFA uptake and synthesis are compensated by
an increased hepatic removal of fatty acids [14].
Carnitine palmitoyl transferase-I (CPT-I), the mitochondrial
gateway for fatty acid entry into the matrix, is the main controller
of the hepatic mitochondrial b-oxidation flux [15]. In the liver,
CPT-I exerts approximately 80% of control under physiological
conditions [16]. The impairment in mitochondrial fatty acid
oxidation due to down-regulation of hepatic CPT-I is a crucial
event in the pathogenesis of hepatic steatosis [17]. To date, the
limited number of studies on CPT-I activity during NAFLD did
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significant reduction of CPT-I activity was observed [18] whereas
CPT-I activity was found not altered in NASH patients [6]. A
remarkable decrease in the expression of the CPT-I gene was
instead reported in patients affected by NAFLD [19,20].
The aim of the present study was to investigate whether
mitochondrial CPT-I activity and then fatty acid oxidation
efficiencyis affected during MCD-induced steatohepatitis.
In our experiments, a noticeable reduction of CPT-I activity,
both in isolated mitochondria and in permeabilized hepatocytes
associated to a decreased fatty acid b-oxidation, measured in
isolated hepatocytes, was detected in MCD-diet fed rats compared
to controls. In the first group of animals an overexpression of
CPT-I gene together with a high level of CPT-I protein oxidation
was revealed. Our hypothesis is that a posttranslational alteration
of CPT-I, occurring during steatohepatitis could be, at least in
part, responsible for the reduced mitochondrial fatty acid b-
oxidation efficiency.
Methods
Animals and experimental design
Adult male Wistar rats (350–400 g) (Harlan, San Pietro al
Natisone, Udine, Italy), were caged individually in a temperature
and light controlled environment with free access to food and
water. Our rats received care in compliance with Italian law (art 4
and 5 of D.L. 116/92). Animals were randomly assigned to the
experimental (MCD) or to the control group. MCD-diet fed rats
(MCD rats) were fed a high fat/Methionine and Choline Deficient
Diet. Control rats consumed the same diet but sufficient in DL-
methionine (3 g/kg) and choline bitartrate (2 g/kg) [4]. Diets were
purchased from Mucedolas. r. l., Settimo Milanese, Milan, Italy
and their compositions have been previously reported [21]. At the
end of 4 weeks of diet administration, 5–8 rats of both groups were
anesthetized by intraperitoneal injection of 100 mg/kg ketamine
and 2.5 mg/kg acepromazine and then sacrificed, their livers
removed and weighed. Liver samples were frozen in liquid
nitrogen until biochemical analyses were performed.
Steatohepatitis was confirmed by histopathological analysis of
liver slices (Fig. 1) and serum alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) activity assays (Table 1) (Sigma-
Aldrich, St. Louis, MO, USA).
Biochemical analysis
Glucose (GOD-POD method), phospholipids (enzymatic color-
imetric method), triacylglycerols (TAG, Triglycerides/GB) and
total cholesterol (CHOD-PAP method) in serum and liver were
determined as in [22], with test kit from Futura System (Rome,
Italy) as specified in parentheses.
Mitochondria isolation
Liver was removed and rapidly processed for preparation of
mitochondria as previously reported [7]. To assess the functional
integrity of isolated mitochondria, we measured mitochondrial
respiration rate by a Clark-type oxygen electrode adding succinate
as substrate. Then, mitochondrial respiration rate in the presence
of ADP (state 3 of mitochondrial respiration) and after ADP
consumption (state 4) was measured. Mitochondria were used for
the experiments when the respiratory control index (state 3/state
4) was .4. Mitochondria protein concentration was determined
using the Lowry micromethod kit (Sigma-Aldrich, St. Louis, MO,
USA).
Table 1. Anthropometric parameters, glucose and lipid content in plasma and liver of rats fed either a control or a methionine-
choline deficient diet.
CTRL MCD P
Body weight (gr) d 0 405.2612.1 399.0623.0 n.s.
d 28 419.7634.9 339.4632.5 ,0.01
Liver weight (gr) 12.962.4 16.261.6 ,0.05
Liver/body weight 0.03160.002 0.05360.004 ,0.005
Serum glucose (mg/dL) d 0 189.8635.1 190.1637.6 n.s.
d 28 199.8638.4 128.8636.2 ,0.05
Serum triacylglycerols (mg/dL) d 0 310.8689.1 318.1698.3 n.s.
d 28 328.76110.8 38.368.8 ,0.001
Serum cholesterol (mg/dL) d 0 57.6611.5 55.8612.8 n.s.
d 28 56.8613.4 28.167.5 ,0.005
Serum phospholipids (mg/dL) d 0 208.1624.1 210.1618.3 n.s.
d 28 207.7622.3 93.5616.6 ,0.001
Serum ALT(U/L) 39.563.9 225.3670.4 ,0.005
Serum AST(U/L) 97.5612.4 163.0636.8 ,0.05
Hepatic phospholipids(nmol/mg prot) 54.168.3 79.067.2 ,0.005
Hepatic triacylglycerols(nmol/mg prot) 50.568.9 253.7631.4 ,0.001
Hepatic cholesterol (nmol/mg prot) 12.863.0 268.5650.1 ,0.001
Hepatic glycogen (nmol/mg prot) 517.5690.3 268.5650.1 ,0.001
Rats were fed a methionine-choline deficient (MCD) or a control (CTRL) diet for 28 days. Data, expressed as means 6 SD of five experiments for each group, are referred
at the beginning of the study (d0) and after 4 weeks (d28). Statistical differences were assessed using unpaired t-test assuming variance homogeneity.
doi:10.1371/journal.pone.0024084.t001
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Hepatocytes were isolated by the collagenase perfusion method
described in [23]. In order to minimize glycogenolysis, 20 mM
glucose was added to the perfusion buffer and to all buffers
subsequently employed in the experiments [23]. Hepatocyte
suspensions were incubated in Krebs-Henseleit bicarbonate buffer
(pH 7.4) (KH buffer) supplemented with 10 mM glucose.
Incubations (4–6 mg of cellular protein/ml) were carried out in
25 ml Erlenmeyer flasks in a metabolic shaker (85 oscillations per
min) at 37uC in a total volume of 2 ml, under an atmosphere of
O2/CO2 (19: 1 v/v).
Enzymatic determinations
CPT-I activity was assayed in rat liver mitochondria as the
incorporation of radiolabelled carnitine into acylcarnitine accord-
ing to Priore et al. [23]. CPT activity insensitive to 100 mmol/L
malonyl-CoA was always subtracted from the CPT activity
experimentally determined [23]. The sensitivity of CPT-I to
malonyl-CoA inhibition was measured as in [22].
Then, CPT-I activity was determined in digitonin-permeabi-
lized cells using 4 mg/ml digitonin (a concentration chosen after
titration with different digitonin concentrations), useful to
permeabilize cell membrane, and palmitoyl-CoA as substrate as
in [24]. Permeabilized hepatocytes allow to assay rapidly
intracellular enzyme activities under more or less physiological
conditions and avoiding any possible post-homogenizing modifi-
cations which can occur in subcellular fractionation [24].
The activity of 3-hydroxy-acyl-CoA dehydrogenase (3-HAD)
was determined spectrophotometrically, in freeze-thawed liver
homogenates, according to Giudetti et al. [22].
The activity of acetyl-CoA carboxylase (ACC) was assayed in
cytosolic fractions by measuring incorporation of [
14C]NaHCO3
into malonyl-CoA [25].
Rate of palmitate oxidation in isolated hepatocytes
Fatty acid total oxidation was followed, in hepatocyte
suspensions, by adding in KH buffer supplemented with 10 mM
glucose, [1-
14C]palmitate bound to BSA in a 5:1 molar ratio. Rate
of [1-
14C]palmitate oxidation was determined as formation of total
oxidation products, i.e. acid-soluble products (ASP), mostly
constituted by ketone bodies, and CO2 [23]. Briefly, 2 mL of
hepatocytes (4–6 mg of cellular protein/ml) were incubated at
37uC in the presence of 0.5 mM albumin-bound [1-
14C]palmitate
(0.1 Ci/mol). After 20 min, reaction was stopped by the addition
of 0.3 ml of 2 M perchloric acid (reactions proceeded at a linear
rate up to 45 min). At the same time, 0.15 ml of benzethonium
hydroxide (1 M in methanol) was injected in a center well
containing filter paper. Samples were allowed to equilibrate for an
additional hour at 4uC, and the center well (with the CO2 fixed as
bicarbonate) was transferred into vials for radioactivity counting.
The cell precipitate was spun down, and supernatants were
washed three times with light petroleum ether. ASP were
subsequently extracted from the samples as in [23]. Total
oxidation products were determined as the sum of CO2 plus ASP.
Immunoprecipitation and Western blotting
Mitochondrial proteins (500 mg) isolated from fresh liver tissue
were immunoprecipitated at 4 Cu overnight with 1 mg anti-CPT-I
antibody (rabbit polyclonal CPT-I-L2-A from Alpha Diagnostic,
San Antonio, Texas, USA) and 50 ml protein G-agarose beads,
using the Protein G Immunoprecipitation Kit (IP-50; Sigma–
Aldrich). The immunoprecipitated proteins were loaded onto 12%
SDS-PAGE gel and transferred to nitrocellulose membrane for
immunoblot analysis with anti-CPT-I antibody (1:2000). The
membrane was then stripped by Restore Stripping Buffer
(#21059; Pierce, Rockford, Illinois, USA) for 30 min, washed
three times and incubated overnight with anti-HNE antibody
(1:1000; Alpha Diagnostic, San Antonio, Texas, USA). Secondary
antibodies were conjugated with horseradish peroxidase and
immunoblots detected by VersaDoc Image System (Bio-Rad
Laboratories, Hercules, California,USA) as previously reported [7].
To measure ACC protein level, 25 mg of total cytosolic proteins
were loaded onto a 7% SDS-polyacrylamide gel. After electro-
phoresis, the proteins were transferred onto a nitrocellulose
membrane. Resulting blot was incubated with ACC antibody
(rabbit polyclonal ACC, from Millipore, Billerica, MA, USA) at a
dilution of 1:4000 at room temperature for 2 h, then membrane
was incubated for 1 h with secondary horseradish peroxidase-
conjugated IgGs (dilution, 1:5000). Signals were detected by
enhanced chemiluminescence. For signal normalization, porin or
a-tubulin were used.
Figure 1. Histological analysis of liver specimens stained with
haematoxylin and eosin (H&E) from controls (A) and rats fed
the MCD diet (B). Liver of rats fed the MCD diet shows steatohepatitis
characterized by panacinar steatosis predominantly as macrovescicular
fat, together with lobular inflammation (H&E 6100).
doi:10.1371/journal.pone.0024084.g001
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Total RNA from rat liver was isolated using the SV Total RNA
Isolation System kit (Promega Italia srl, Milan, Italy), following
manufacturer’s instructions. RT reaction (20 ml) was carried out
using 5 mg of total RNA, 100 ng of random hexamers and 200 U
SuperScript
TM III RNase H-Reverse transcriptase (Invitrogen srl,
San Giuliano Milanese, Milan, Italy). Quantitative gene expres-
sion analysis was performed (SmartCycler System, Cepheid) using
SYBR Green technology (Celbio, Milan, Italy) and 18S rRNA, for
normalization. The primers used for real time PCR analysis were
the following:
CPT-I RATFOR 59-CACTGGCCGAATGTCAAG-39
CPT-I RATREV 59-CACGGCTGGATGTTTGCA-39
18S RATFOR 59-GTTGGTTTTCGGAACT-
GAGGC-39
18S RATREV 59-GTCGGCATCGTTTATGGTCG-
39
Measurement of mitochondrial HNE-protein adducts
Liver mitochondria fluorescent adducts formed between 4-
Hydroxy-2-Nonenal (HNE) and proteins were monitored by
spectrofluorimetry as previously reported [7].
Fatty acid analysis
To analyze fatty acids, liver mitochondria were saponified with
ethanolic KOH for 2 h at 90uC. Fatty acids were extracted [25]
and their corresponding methyl esters (FAMEs) were prepared by
trans-esterification with 17% methanolic boron trifluoride (BF3)a t
65uC for 30 min. FAMEs were then analyzed by gas-liquid
chromatography [25]. Peak identification was performed by using
known standards and relative quantitation was automatically
carried out by peak integration.
Statistical analysis
Data are expressed as means 6 standard deviations (SD). The
unpaired t test was used to assess the significance of differences
between means. In all instances P,0.05 was taken as the lowest
level of significance. The package GraphPad Prism 4 for Windows
(GraphPad Software Inc., San Diego, CA, USA) was used to
perform all the statistical analyses.
Results
Anthropometric parameters
MCD rats displayed significant weight loss after 28 days with
respect to control, although liver weight increased (Table 1). As a
consequence, liver/body weight ratio augmented in MCD rats
(Table 1). Both these alterations could be taken into account for
the onset of steatosis.
Lipid and glucose content of serum and liver
Serum glucose was significantly reduced after 28 days of the
MCD diet administration; a large depletion of serum TAG was
also observed in MCD with respect to control rats (Table 1). In the
same way, serum concentrations of cholesterol and phospholipids
were significantly lowered in the MCD rats when compared to
control. Moreover, serum transaminase (ALT and AST) levels
were significantly higher in MCD than control rats, indicating an
hepatic damage, confirmed also by the histopathological analysis
of liver slices (Fig. 1).
TAG and cholesterol levels increased several times in the liver of
MCD as compared to control rats (Table 1). Conversely, hepatic
glycogen was decreased by about 53% in steatotic liver compared
to control (Table 1). Taken together, these data show that the
MCD diet markedly modifies liver lipid profile leading to serum
lipid modifications.
CPT-I activity in isolated mitochondria
Hepatic fatty acid oxidation was studied using different
approaches. Firstly the activity of CPT-I was measured in
mitochondria isolated from control and steatotic liver. CPT-I
activity was significantly reduced (,33%) in mitochondria of
MCD rats when compared to controls (Fig. 2A). The process of
hepatic fatty acid oxidation is controlled not only by CPT-I
specific activity but also by its sensitivity to the level of malonyl-
CoA [16] produced by the first step of fatty acid synthesis
catalyzed by ACC. Moreover, CPT-I sensitivity to malonyl-CoA is
regulated by changes in lipid composition that are localized to
specific membrane microdomains [26]. Thus, hepatic CPT-I
sensitivity to malonyl-CoA inhibition was determined.
Interestingly, in steatotic liver the reduced CPT-I activity was
accompanied by a decrease (,36%) in sensitivity to malonyl-CoA
(Fig. 2B).
Once in mitochondrial matrix, fatty acids are oxidized by the b-
oxidation pathway. A remarkable reduction in the activity of 3-
hydroxy-acyl-CoA dehydrogenase (3-HAD), key enzyme of the
mitochondrial matrix b-oxidation process, was observed in liver
mitochondria of MCD rats as compared to controls (Fig. 3).
Assay of ACC activity
As above reported, short-term control of CPT-I activity involves
inhibition by malonyl-CoA produced by ACC. Because the latter
enzyme is a key regulatory site of de novo fatty acid synthesis,
malonyl-CoA inhibition of CPT-I allows an elegant explanation
for the coordinate control of the partition of hepatic fatty acids into
esterification and oxidation [16].
Specific activity of ACC was significantly lower in MCD than in
control rats (0.660.04 vs 1.560.71 nmol/min/mg protein,
P,0.001) (Fig. 4A). ACC protein content, assayed by Western
blot analysis, decreased in parallel with the activity (Fig. 4B).
CPT-I assay in permeabilyzed hepatocytes
It has been demonstrated that the activity of liver CPT-I is
affected by extramitochondrial cell components that are lost on
isolation of mitochondria [24]. Permeabilizing cells with digitonin
opens the possibility of investigating intracellular enzymes in a
more or less natural environment. This experimental tool is
particularly useful when interactions exist among cytosolic
enzymes, such as ACC, with organelle associated enzymes, if
their active centre faces the cytosolic space as is the case of CPT-I
[24]. A noticeable sensitivity of the latter enzyme to the malonyl-
CoA level was observed in permeabilized hepatocytes [24], thus
indicating that this approach is very suitable for investigating the
ACC/malonyl-CoA/CPT-I system.
At this point, it is important to underline that CPT-I activity,
assayed in situ by using digitonin-permeabilized hepatocytes,
showed an inhibition (0.1960.01 nmol/min/10
6 cells of MCD
rats vs 0.2660.02 nmol/min/10
6 cells of controls; n=3, P,0.05)
of the same extent found in isolated mitochondria.
In situ fatty acid oxidation assay
Next, total rate of fatty acid oxidation was investigated following
the oxidation of [1-
14C] palmitate added to hepatocyte suspen-
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acids, can enter the citric acid cycle to be degraded to CO2 for
energy production if the supply of oxaloacetate is sufficient or,
alternatively, can give rise to ketone bodies (i.e. acid soluble
products, ASP). Therefore, the total oxidation of fatty acids is a
summation of the metabolism towards ASP and CO2. We found
that either CO2 production and particularly ASP formation were
significantly lower in hepatocytes from MCD rats than in those
from controls (Fig. 5). Consequently, total [1-
14C]palmitate
oxidation was reduced (,30%) in hepatocytes from MCD animals
with respect to controls (9.160.6 nmol/h/10
6 cells of MCD vs
13.360.9 nmol/h/10
6 cells of control; n=3, P,0.05). Note that
the percentage of inhibition of fatty acid oxidation in hepatocytes
from MCD rats well correlates with the decrease of CPT-I activity
measured in isolated mitochondria (see Fig. 2A).
CPT-I protein and mRNA expression
To investigate the molecular mechanism underlying the MCD-
induced decrease of CPT-I activity, CPT-I mRNA and protein
levels were quantified by Real Time PCR and Western blot
analysis, respectively. To this end, total RNA was isolated from
liver of MCD and control rats and Real-time qPCR analysis was
performed. As shown in Fig. 6A an increase of approx. 70% of
CPT-I mRNA abundance was observed in MCD rats when
compared to controls.
Next, CPT-I expression was investigated by Western blot
analysis (Fig. 6B). As shown in the figure, densitometric analysis
indicated that liver mitochondrial CPT-I protein level in MCD
rats was considerably higher (approx. 40%) than in the control
ones. Porin, the mitochondrial outer membrane channel, was used
as a control protein, because it has been reported that its
expression is not affected by dietary treatment [27].
Protein oxidation assay
Accumulating evidence suggests that mitochondrial dysfunction
participates in NASH pathogenesis, since it impairs fatty liver
homeostasis and induces overproduction of ROS [14]. These
latter, in turn, trigger lipid peroxidation, cytokines release and cell
death. Aldehydes, such as HNE, are major end products of lipid
peroxidation and, by constituting adducts with proteins, can
accumulate in tissues under oxidative stress [14].
Previous reports have demonstrated HNE-protein adduct
formation in several experimental models of NASH [28,29]. We
have also demonstrated the occurrence of the adducts in the MCD
model [7].
In the present work HNE-protein adducts significantly
increased in the liver of MCD rats as compared to controls
(Fig. 7A).
To test the hypothesis that impairment in CPT-I activity could
be related to protein oxidation, mitochondrial proteins were
Figure 3. Effects of the methionine-choline deficient (MCD) diet
on 3-hydroxy-acyl-CoA dehydrogenase (3-HAD) activity. Activ-
ity of 3-HAD of control (CTRL) and methionine-choline deficient (MCD)
diet fed rats was measured spectrophotometrically as described in
‘‘Methods’’. Data are expressed as means 6 SD of five experiments for
each group. Statistical differences were assessed using unpaired t-test
assuming variance homogeneity. *Significantly different from the
control.
doi:10.1371/journal.pone.0024084.g003
Figure 2. Carnitine palmitoyl transferase-I (CPT-I) activity and
sensitivity to malonyl-CoA in isolated mitochondria. Activity of
CPT-I (A) and its sensitivity to malonyl-CoA (B) was measured in isolated
liver mitochondria from both control (CTRL) and methionine-choline
deficient (MCD) diet fed rats. CPT-I activity is reported as nmoles
[
14C]carnitine incorporated into acylcarnitine/min/mg protein. CPT-I
sensitivity to malonyl-CoA was expressed as percentage of inhibition to
10 mM malonyl-CoA. Data are expressed as means 6 SD of five
experiments for each group. Statistical differences were assessed using
unpaired t-test assuming variance homogeneity. *Significantly different
from the control.
doi:10.1371/journal.pone.0024084.g002
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by using anti-HNE-protein adduct antibody [7]. As reported in
Fig. 7B, a signal consistent with HNE-CPT-I adduction was
observed almost exclusively in mitochondria from MCD rats (65%
of the total CPT-I protein content).
Fatty acid composition of hepatic mitochondrial
membranes
Fatty acid composition of mitochondrial membranes from liver
of control and MCD rats was then analyzed. Even though the
ratio of saturated to unsaturated fatty acids in MCD rats was
unaltered, a significant decrease in linoleic and arachidonic acids,
both of the n-6 series, occurs together with an increase in the
docosapentaenoic and docosahexaenoic acids (Table 2). In
agreement with Rizki et al. [30] which reported an inhibitory
effect of MCD diet on the stearoyl-CoA desaturase-1 activity in
mouse liver, a reduction of oleic and palmitoleic acid levels was
also observed in mitochondria of MCD animals, when compared
to controls.
Discussion
Steatosis, induced in rodents by an MCD diet, presents
pathological and biochemical similarities with human steatohepa-
titis, although it does not induce insulin resistance [31]. The
absence in the diet of choline and methionine, which are
precursors for the biosynthesis of phosphatidylcholine, an essential
component of plasma lipoproteins, interferes with the synthesis
and secretion of the very low density lipoproteins (VLDL). In these
conditions the strong reduction in the transport of TAG by VLDL
out of the hepatocytes leads to steatosis [32].
Impaired hepatic oxidation and removal of fatty acids may also
contribute to the raise in lipid content in liver of MCD mice [30].
Our data confirm increased lipid accumulation, mainly as TAG,
in the liver of MCD rats together with a reduction in the serum
lipid level (see Table 1) probably due to a phospholipid-related
defect in hepatic secretion [30].
The present study shows that MCD diet, administered to rats
for 4 weeks, decreases CPT-I activity both in isolated mitochon-
dria and in permeabilized hepatocytes thus producing pronounced
effects on hepatic lipid metabolism that go beyond the simply
inhibition of TAG secretion.
The role of liver mitochondrial CPT-I, key enzyme of fatty acid
oxidation pathway, in steatosis onset and/or progression is still
matter of debate.
To date, few and controversial results on CPT-I activity and/or
expression modifications occurring during NASH development,
have been reported. Perez-Carreras et al. [6] did not find any
difference in the liver CPT-I activity of NASH patients as
compared to controls. However, Nakamuta et al. [19] evaluating
the expression of fatty acid metabolism-related genes in NASH
patients, found a remarkable increase of ACC mRNA abundance,
but a decrease of CPT-I expression thus suggesting a posttran-
scriptional mechanism for CPT-I regulation In a rodent
nutritional model of NASH a significant reduction of CPT-I
activity, together with a decreased CPT-I sensitivity to malonyl-
CoA, was observed. This reduction was ascribed to the nitration of
the protein [18].
Such diversity of results may be related to differences in the
grade and the stage of NASH, in the model adopted and in the
methods used to measure CPT-I activity and expression.
Figure 4. Activity and protein level of acetyl-CoA carboxylase
(ACC). ACC activity (A) and protein level (B) in control (CTRL) and
methionine-choline deficient (MCD) diet fed rats were measured as
reported in ‘‘Methods’’. ACC activity is expressed as nmoles
[
14C]NaHCO3 incorporated into malonyl-CoA/min/mg protein. a-Tubulin
was used for signal normalization. Data are expressed as means 6 SD of
five experiments for each group. Statistical differences were assessed
using unpaired t-test assuming variance homogeneity. *Significantly
different from the control.
doi:10.1371/journal.pone.0024084.g004
Figure 5. Palmitate oxidation by rat hepatocytes. Hepatocytes
were incubated with [1-
14C]palmitate. Total fatty acid oxidation was
obtained as the sum of CO2 and total acid-soluble products (ASP).
Results, expressed as [1-
14C]palmitate into product/h/10
6 cells, corre-
spond to means 6 SD of three different experiments. *Significantly
different from the control.
doi:10.1371/journal.pone.0024084.g005
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offer a closer physiological environment to study mitochondrial
processes under precisely controlled conditions in situ, where
mitochondrial interaction with intracellular structures, is largely
preserved [24]. In the present study we measured a reduced
activity of CPT-I in digitonin-permeabilized hepatocytes from
MCD rats. The lower CPT-I activity measured in treated animals
well correlate with the decreased activity of the key mitochondrial
matrix enzyme 3-HAD (Fig. 3) and with the low rate of total fatty
acid oxidation measured in hepatocyte suspensions (Fig. 5). Such
inhibition may contribute to the accumulation of fatty acids that
enter the pathway of esterification determining a further increase
of hepatic TAG amount, as indeed found (Table 1).
In the present work we also report, in MCD rats, an over-
expression of CPT-I gene as indicated by the increment of both
CPT-I mRNA abundance and protein levels. To explain why,
despite a higher CPT-I expression, we measured a low CPT-I
activity during NASH, when compared to controls, we assume
that CPT-I over-expression could occur into the liver during the
onset of steatosis, to counteract the elevated fatty acid level as
Figure 6. mRNA and protein levels of rat liver CPT-I. The
histogram (A) represents CPT-I mRNA abundance determined using RT-
quantitative PCR and expressed as relative amount (18s rRNA as a
reference) in liver from control (CTRL) and methionine-choline deficient
(MCD) diet fed rats (A). Data are shown as mean values 6 SD for the
CPT-I gene relative to an arbitrary value of 1, which was assigned to the
expression level in control animals. Western blot analysis of CPT-I in liver
from CTRL and MCD rats (B) was performed as reported in ‘‘Methods’’.
Porin was used for signal normalization. The content of CPT-I was
quantified by densitometric analysis. Data are mean values 6 SD of five
experiments for each group. *Significantly different from the control.
doi:10.1371/journal.pone.0024084.g006
Figure 7. HNE-protein adducts in liver mitochondria. (A) Levels
of HNE-protein adducts in liver mitochondria from methionine-choline
deficient (MCD) diet and control rats (CTRL) were measured by
fluorimetric analysis and evaluated in terms of arbitrary fluorescent
units (A.F.U.) at 355 nm excitation and 460 nm emission. Data are
expressed as means 6 SD of five experiments for each group. (B)
Western blot analysis was performed to reveal HNE-CPT-I adducts from
CTRL and MCD rats. Signals were quantified by densitometric analysis
and expressed as % of the total CPT-I protein content measured in
mitochondria from CTRL and MCD rats. Statistical differences were
assessed using unpaired t-test assuming variance homogeneity.
*Significantly different from the control.
doi:10.1371/journal.pone.0024084.g007
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could, subsequently, reverse the effect. The reduction of CPT-I
sensitivity to malonyl-CoA together with the inhibition of ACC
activity and expression we measured, could further support the
idea that a compensatory mechanism, acting through a regulation
of the ACC/malonyl-CoA/CPT-I system [33], is triggered in the
first phase of NASH, when liver is still steatotic, to facilitate fatty
acid oxidation.
At this point it must be underlined that increased mitochondrial
fatty acid b-oxidation, insteatotic liver, is a widely recognized
event [14]. Fromenty et al [11] claim that, to avoid an indefinite
enlargement, steatotic liver reaches a new metabolic steady state
characterized by high rates of mitochondrial fatty acid b-oxidation
[11].
The process by which steatosis falls into steatohepatitis is a topic
of great interest. Studies have recently provided persuasive
evidences that oxidative stress occurs in several different animal
models of steatohepatitis and in patients with NASH [34]. In both
cases the degree of lipid peroxidation correlates with the severity of
steatosis [34]. ROS-mediated lipid peroxidation is an attractive
candidate for a central role in the pathogenesis of NASH.
HNE, a very reactive electrophilic aldehydes created by
peroxidation of n-6 fatty acids, such as arachidonic and linoleic
acid esters, can covalently attach to proteins by forming adducts
with cysteine, lysine, or histidine residues, thereby damaging the
protein structure. Such damage may affect the protein function
and its own catabolism [34,35]. HNE has been readily detected in
the mitochondria of hepatocytes in patients with NASH [36]. In
our experiments a reduced level of liver mitochondria n-6 fatty
acids (see Table 2), probably due to their increased peroxidation,
was detected in MCD rats. Since HNE is the main product of n-6
fatty acid oxidation, we tested whether HNE may bind CPT-I
during steatosis and we observed HNE-CPT-I adducts were
almost exclusively present in the liver of MCD rats (see Fig. 7).
Note that, in the same animal model we have previously reported
the formation of an adduct between HNE and UCP-2 and a
consequent modification of the activity of the bounded protein [7].
Therefore, CPT-I protein oxidation, causing a decrease in the
amount of active protein, could account for the reduced activity
measured in our experiments despite the higher level of CPT-I
expression.
In conclusion, the present work shows that during NASH,
induced by MCD dietary treatment, some products of oxidative
stress, such as HNE, may bind and modify proteins as CPT-I. The
aldheyde-protein interaction could interfere with the fatty acid
transport into mitochondria and therefore with their oxidation,
leading to an impairment in lipid removal.
To our knowledge, our data represent the first evidence
reporting covalent modification occurring on CPT-I during
steatohepatitis. However, the fully understanding of the relation-
ship between oxidative stress and development of steatohepatitis
requires further elucidations.
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